Flukolodeks forte - instructions for use, dose, side effects, contraindications

Active substanceCaffeine + Paracetamol + Phenylephrine + Terpin hydrate + Ascorbic acidCaffeine + Paracetamol + Phenylephrine + Terpin hydrate + Ascorbic acid

Similar drugsTo uncover

Fluxoldex® forte

pills inwards

Outline Pharma Pvt. Ltd. India

Dosage form: & nbspPills

Composition:

Each tablet contains active ingredients:

Paracetamol 500 mg

Phenylephrine hydrochloride 5 mg

Caffeine anhydrous 25 mg

Terpin hydrate 20 mg

Ascorbic acid 30 mg

(Vitamin C)

Description:

Round biconvex tablets covered with an orange-colored shell with marbling, a core of light orange color with orange and white impregnations.

Pharmacotherapeutic group:ARI and "colds" of symptoms remedy (analgesic non-narcotic means + alpha-adrenomimetic + psychostimulant + expectorant + vitamin).

ATX: & nbsp

N.02.B.E Anilides

Pharmacodynamics:

Combined drug. Paracetamol has antipyretic and analgesic effect: reduces pain syndrome, which is observed in catarrhal conditions - sore throat, headache, muscle and joint pain, reduces heat. Phenylephrine has vasoconstrictive effect - reduces edema and hyperemia of the mucous membranes of the upper respiratory tract and accessory sinuses. Caffeine has a stimulating influence on the central nervous system, which leads to a reduction in fatigue and drowsiness, increased mental and physical performance. Terpin hydrate has an expectorant effect. Ascorbic acid (vitamin C) replenishes the increased need for vitamin C for colds and flu, especially in the initial stages of the disease.

Indications:

Symptomatic treatment of "cold" diseases, flu, ARVI (febrile syndrome, pain syndrome, rhinorrhea).

Contraindications:

Hypersensitivity to paracetamol and other components that make up the drug; reception of other preparations containing substances included in Flukoldeks Forte, simultaneous administration of tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, beta-blockers; pregnancy, lactation; children's age (up to 6 years).

Carefully:Carefully - pronounced arteriosclerosis of the coronary arteries, arterial hypertension, thyrotoxicosis, pheochromocytoma, diabetes mellitus, bronchial asthma, chronic obstructive pulmonary disease, glucose-6-phosphate dehydrogenase deficiency, blood diseases,congenital hyperbilirubinemia (Gilbert syndrome, Dubin-Johnson and Rotor syndrome), hepatic and / or renal insufficiency, angle-closure glaucoma, prostatic hyperplasia.

Pregnancy and lactation:contraindicated

Dosing and Administration:

Adults and children over 12 years: 2 tablets up to 4 times a day (do not take more than 8 tablets in 24 hours). Children from 6 to 12 years: 1 tablet up to 4 times a day (do not exceed the dose of 4 tablets per 24 hours). Do not give children younger than 6 years old without consulting a doctor.

If symptoms persist for 3-5 days, consult a physician. Do not exceed the indicated dose.

Side effects:

Allergic reactions (including skin rash, itching, hives, angioedema), dizziness, falling asleep, increased excitability, mydriasis; increased blood pressure, tachycardia; nausea, vomiting, epigastric pain; dry mouth; retention of urine, paresis of accommodation, increased intraocular pressure; anemia, thrombocytopenia, agranulocytosis, hemolytic anemia, aplastic anemia, methemoglobinemia, pancytopenia; hepatotoxic effect, nephrotoxicity (papillary necrosis); bronchial obstruction.

Overdose:Conditional, as a rule, paracetamol, appears after taking more than 10-15 g of the latter. Possible: pallor of the skin, anorexia, nausea, vomiting; hepatonecrosis; an increase in the activity of "hepatic" transaminases, an increase in prothrombin time. When overdosing, it is urgent to see a doctor.
Treatment: gastric lavage followed by the administration of activated charcoal; symptomatic therapy, the introduction of methionine after 8-9 hours after an overdose and N-acetylcysteine - after 12 h.

Interaction:

Strengthens the effects of MAO inhibitors, sedatives, ethanol. Antidepressants, antiparkinsonics, antipsychotics, phenothiazine derivatives - increase the risk of urinary retention, dry mouth, constipation. Glucocorticosteroids increase the risk of developing glaucoma. Paracetamol reduces the effectiveness of diuretic drugs. Tricyclic antidepressants strengthen the adrenomimetic effect of phenylephrine, the simultaneous administration of halothane increases the risk of ventricular arrhythmia. Reduces the hypotensive effect of guanethidine, which, in turn, enhances the alpha adrenostimulating activity of phenylephrine.With the simultaneous appointment of Flukoldex Forte with barbiturates, diphenin, carbamazepine, rifampicin and other inducers of microsomal liver enzymes, the risk of hepatotoxic action of paracetamol increases.

Special instructions:During treatment should refrain from taking alcohol, sleeping pills and anxiolytic (tranquilizers) medicines. Distorted results

laboratory tests assessing the concentration of glucose and uric acid in the plasma. Do not use other medicines containing paracetamol, as well as other non-narcotic analgesics, non-steroidal anti-inflammatory drugs (metamizol, ibuprofen and the like), barbiturates, antiepileptic drugs, rifampicin, chloramphenicol.

Excessive consumption of tea or coffee during the reception of Flukoldeks Forte can cause irritability and nervous tension. If the symptoms do not go away within 3-5 days, consult a doctor.

Effect on the ability to drive transp. cf. and fur:not described

Form release / dosage:

Film coated tablets.

For 12 tablets in aluminum foil and PVC foil blisters.For 1 blister pack in a pack together with instructions for use.

Packaging:packs cardboard

Storage conditions:

At a temperature of no higher than 25 ° C in a dark place.

Keep out of the reach of children.

Shelf life:

3 years. Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:LSR-001559/08

Date of registration:14.03.2008

The owner of the registration certificate:Outline Pharma Pvt. Ltd.Outline Pharma Pvt. Ltd. India

Manufacturer: & nbsp

NABROS PHARMA, Pvt. Ltd. India

Representation: & nbspKORAL-MED, CJSCKORAL-MED, CJSC

Information update date: & nbsp19.11.2010

Illustrated instructions

Instructions

Fluxoldex® forte (Flucoldex® forte)